Winter U J, Sedlak M P, Gitt A K, Fritsch J, Deutsch H J, Berge P G, Hilger H H, Südkamp M, de Vivie E R
Klinik III für Innere Medizin der Universität zu Köln.
Z Kardiol. 1994;83 Suppl 3:121-9.
In this study we wanted to investigate if noninvasive cardiopulmonary exercise testing can be securely, accurately applied in patients with acquired cardiac valve disease pre- and postoperatively with any convenience. Furthermore, we looked if the cardiopulmonary exercise capacity (anaerobic threshold, etc.) was improved postoperatively (3 and 6 months) in 15 patients suffering from severe mitral valve disease as compared to the preoperative condition. The symptom-limited cardiopulmonary exercise testing was performed on a bike in a semi-supine position using a ramp program (+20 W/min). The following parameters were continuously monitored, and the breath-by-breath gas exchange values documented: cardiocirculatory parameters (heart rate; blood pressure; surface ECG; exercise capacity in Watts); gas-exchange parameters (O2-uptake VO2; CO2-production VCO2; respiratory anaerobic threshold VO2 AT; gas-exchange ratio VCO2/VO2; O2-pulse VO2/HR; aerobic capacity delta VO2/delta WR) and ventilatory parameters (respiratory rate; tidal volume Vt; minute ventilation VE; equivalent for O2: VE/VO2 and CO2: VE/VCO2). The 155 cardio-pulmonary exercise tests in 115 patients were practicable, safe (no emergency case) and accurate. In 100 patients late postoperatively (68.3 +/- 53.0 -102.9 +/- 41.2 months) after aortic or mitral valve replacement or both without signs of significant hemolysis or prosthetic valve dysfunction the NYHA classification was too imprecise to characterize the actual exercise capacity of the patients (e.g., NYHA class II: Weber class B to E). Patients with aortic valve prosthesis had a significantly better anaerobic threshold (57.4 +/- 19.1% pred. value max. VO2) as compared to those with mitral valve replacement (mean: 35.9% pred. value max. VO2).(ABSTRACT TRUNCATED AT 250 WORDS)
在本研究中,我们想要探究无创心肺运动试验能否安全、准确且便捷地应用于获得性心脏瓣膜病患者的术前和术后。此外,我们观察了15例重度二尖瓣疾病患者术后(3个月和6个月)与术前相比,心肺运动能力(无氧阈等)是否有所改善。症状限制性心肺运动试验在半卧位的自行车上采用斜坡程序(每分钟增加20瓦)进行。持续监测以下参数,并记录逐次呼吸的气体交换值:心脏循环参数(心率、血压、体表心电图、以瓦为单位的运动能力);气体交换参数(氧摄取量VO₂、二氧化碳产生量VCO₂、呼吸无氧阈VO₂AT、气体交换率VCO₂/VO₂、氧脉搏VO₂/HR、有氧能力增量VO₂/增量WR)和通气参数(呼吸频率、潮气量Vt、分钟通气量VE、氧当量:VE/VO₂和二氧化碳当量:VE/VCO₂)。115例患者的155次心肺运动试验可行、安全(无紧急情况)且准确。在100例患者术后晚期(主动脉瓣或二尖瓣置换术后或两者皆有,68.3±53.0 - 102.9±41.2个月),无明显溶血或人工瓣膜功能障碍迹象,但纽约心脏病协会(NYHA)分级过于不精确,无法描述患者的实际运动能力(例如,NYHAⅡ级:韦伯B级至E级)。与二尖瓣置换患者相比,主动脉瓣置换患者的无氧阈明显更好(最大摄氧量预测值的57.4±19.1%)(二尖瓣置换患者平均为最大摄氧量预测值的35.9%)。(摘要截选至250词)